Not long to wait for an update on the CANON clinical trial.
http://eaumunich2016.uroweb.org/sci...ession/new-technologies-in-endo-urology/7558/
Monday 14th March
13:28 - 13:32
Late Breaking News: Phase I/II CANON study: Novel oncolytic immunotherapy for the treatment of Non-Muscle Invasive Bladder Cancer using intravesical CAVATAK (Coxsackievirus A21)
H. Pandha, Guildford (GB)
.....
- Forums
- ASX - By Stock
- VLA
- Todays Volume . Sorry !
Todays Volume . Sorry !, page-12
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online